Cargando…
Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
BACKGROUND: The reemergence of yellow fever virus (YFV) in Africa and Brazil, and massive vaccine campaigns triggered to contain the outbreaks, have raised concerns over blood transfusion safety and availability with increased risk of YFV transfusion‐transmitted infections (TTIs) by native and vacci...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078960/ https://www.ncbi.nlm.nih.gov/pubmed/31957887 http://dx.doi.org/10.1111/trf.15673 |